Trial intelligence / Profile preview

Ketamine for Alcohol Dependence (KARE)

NCT02649231Phase 2Completed

Sponsor
University College London
Start
Oct 2016
Primary completion
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ketamine in alcohol use disorder (AUD), sponsored by University College London. Started Oct 2016; status: completed.

02

Drugs

ketamine
03

Conditions

alcohol use disorder (AUD)

Beyond the preview

Go deeper on NCT02649231.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02649231.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call